Subscribe: DeviceSpace.com All News
http://rss.biospace.com/ds_allnews.rss
Preview: DeviceSpace.com All News

Biotech, Pharmaceutical and Clinical Research News | BioSpace



RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by Feedity)



Published: Tue, 20 Feb 2018 17:22:19 GMT

Last Build Date: Tue, 20 Feb 2018 17:22:19 GMT

 



FDA Gives AstraZeneca’s Imfinzi the Nod for New Lung Cancer Indication

Tue, 20 Feb 2018 00:00:00 GMT

(image) The U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Imfinzi to treat patients with unresectable Stage III non-small cell lung cancer (NSCLC).


Media Files:
http://www.biospace.com/getasset/dd76c052-9fe5-499f-b11f-94377bf970fd/




Federal Court Overturns Gilead Sciences and Merck Patent Dispute

Tue, 20 Feb 2018 00:00:00 GMT

(image) Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision.


Media Files:
http://www.biospace.com/getasset/1340b469-a92e-4b38-8154-aab619301a11/




J&J Could Explore Potential $2B Sale of Sterilization Products Division

Tue, 20 Feb 2018 00:00:00 GMT

(image) Life sciences giant Johnson & Johnson may be shopping around its sterilization products division.


Media Files:
http://www.biospace.com/getasset/0f84515b-6219-4f4f-8f70-2c591910cebe/




AbbVie and Voyager Therapeutics Launch $1.2 Billion+ Alzheimer’s Partnership

Tue, 20 Feb 2018 00:00:00 GMT

(image) AbbVie and Voyager Therapeutics inked a collaboration deal to develop treatments for Alzheimer’s disease and other neurodegenerative diseases.


Media Files:
http://www.biospace.com/getasset/9035b745-e2e3-4c29-b8a4-c1d585b0c7d7/




Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B

Tue, 20 Feb 2018 00:00:00 GMT

(image) Dynavax announced it has secured a $175 million non-dilutive term loan agreement to commercialize Heplisav-B.


Media Files:
http://www.biospace.com/getasset/d62646cb-d2e1-481d-9eb1-1c7ad5aba250/




PDL BioPharma Gives Up on Acquiring Neos Therapeutics

Tue, 20 Feb 2018 00:00:00 GMT

(image) Nevada-based PDL BioPharma, Inc. said it will no longer pursue a proposed acquisition of Neos Therapeutics.


Media Files:
http://www.biospace.com/getasset/0fbd1014-5dd0-4a4c-b4a0-8d2a201bccc4/